Replies to post #474 on NeurogesX Inc (fka NGSX)

[ShysterChaser]

Now if they could only get some bux put together so that they could open Phase 3 trials for the latest iter of red hot chili pepper juice derivatives! All IMHO.

[surf1944]

11:01AM Neurogesx NGX-1998 was well-tolerated treatment demonstrated clear dose-response in patients (NGSX) 0.24 +0.02 : Co presented data from its Phase 2 study on NGX-1998 at the 14th World Congress on Pain in Milan, Italy. NGX-1998 is the Company's next generation liquid formulation of prescription-strength capsaicin. The presentation highlighted the Company's Phase 2 clinical trial, a multicenter, placebo-controlled, double-blind trial in postherpetic neuralgia (PHN). The results from the trial indicate that NGX-1998 may be a safe, efficacious and convenient treatment for patients with PHN and other types of neuropathic pain. NeurogesX plans to enable a Phase 3 clinical trial in neuropathic pain by the end of 2012.